Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL530167 | 0.84 | ACACB (0.33) | ACACBACACA | |
| SCHEMBL10785460 | 0.83 | ACACB (0.35) | ACACBACACA | |
| SCHEMBL4952705 | 0.82 | ACACB (0.32) | ACACBACACA | |
| SCHEMBL139346 | 0.67 | ACACB (0.32) | ACACBACACA | |
| SCHEMBL284229 | 0.67 | ACACB (0.32) | ACACBACACA | |
| SCHEMBL23277366 | 0.67 | USP2 (0.41) | — | |
| SCHEMBL29460322 | 0.67 | — | — | |
| SCHEMBL10790473 | 0.66 | CYP4F2 (0.33) | ACACBACACA | |
| SCHEMBL194106 | 0.66 | LMNA (0.32) | ACACBACACA | |
| SCHEMBL1660177 | 0.65 | ACACB (0.39) | ACACBACACA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110166293-A1 | COMPOSITION CONTAINING (METH)ACRYLIC POLYMER AND COPOLYMER HAVING ASSOCIATIVE GROUPS | ARKEMA FRANCE (FR) | 2011-07-07 | — | — | US | disclosed |
| US-20110065866-A1 | Composition containing a halogenated vinyl polymer and a copolymer bearing associative groups | ARKEMA FRANCE (FR) | 2011-03-17 | — | — | US | disclosed |
| US-20090170958-A1 | USE OF PARTICULAR POLYMERS OR COPOLYMERS AS SURFACTANTS FOR STABILIZING LATICES | ARKEMA FRANCE (FR) | 2009-07-02 | — | — | US | disclosed |
| US-20080274074-A1 | Method for Controlled Free Radical Polymerization or Copolymerization of Methacrylic and/or Methacrylate Monomers or Exclusively Methacrylic and/or Methacrylate Copolymers | ARKEMA FRANCE (FR) | 2008-11-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080274074-A1 | Method for Controlled Free Radical Polymerization or Copolymerization of Methacrylic and/or Methacrylate Monomers or Exclusively Methacrylic and/or Methacrylate Copolymers | PRMT9, MMAB, PRMT8 | ACACB 3261/4885ACACA 3022/4885 |
| US-20090170958-A1 | USE OF PARTICULAR POLYMERS OR COPOLYMERS AS SURFACTANTS FOR STABILIZING LATICES | LATS1, LATS2, LTN1 | ACACB 4214/4885ACACA 3814/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.